Day: January 25, 2024

Conference Call Scheduled for 8:00 a.m. ET on February 22, 2024 AUSTIN, Texas, Jan. 25, 2024 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading Open SaaS ecommerce platform for fast-growing and established B2C and B2B brands, today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, before market open on Thursday, February 22, 2024. The financial results and business highlights will be discussed on a conference call and webcast scheduled at 7:00 a.m. CT (8:00 a.m. ET) on Thursday, February 22, 2024. The conference call can be accessed by dialing (833) 634-1254 from the United States and Canada or (412) 317-6012 internationally and requesting to join the “BigCommerce conference call.” The live webcast of the conference call can be accessed...

BEDMINSTER, NJ, Jan. 25, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) (the “Company”) announces its fourth quarter 2023 financial results. This earnings release should be read in conjunction with the Company’s Q4 2023 Investor Update, a copy of which is available on our website at www.pgbank.com and via a current report on Form 8-K on the website of the Securities and Exchange Commission at www.sec.gov.  The Company recorded total revenue of $54.3 million, net income of $8.6 million and diluted earnings per share (“EPS”) of $0.48 for the quarter ended December 31, 2023, compared to revenue of $64.9 million, net income of $20.6 million and diluted EPS of $1.12 for the quarter ended December 31, 2022. The net interest margin stabilized at 2.29% for the quarter...

4th Quarter 2023 Highlights:Net income was $54.3 million for the current quarter, an increase of $1.9 million, or 4 percent, from the prior quarter net income of $52.4 million. Net income for the current quarter decreased $25.4 million, or 32 percent, from the prior year fourth quarter net income of $79.7 million, which was primarily driven by an increase in cost of funds. Interest income of $273 million in the current quarter increased $8.6 million, or 3 percent, over the prior quarter interest income of $265 million. Interest income in the current quarter increased $48.4 million, or 22 percent, over the prior year fourth quarter. The loan portfolio of $16.198 billion increased $63.0 million, or 2 percent annualized, during the current quarter. The loan yield for the current quarter of 5.34 percent, increased 7 basis points, compared...

Shreveport, Louisiana, Jan. 25, 2024 (GLOBE NEWSWIRE) — Home Federal Bancorp, Inc. of Louisiana (the “Company”) (Nasdaq: HFBL), the holding company of Home Federal Bank, reported net income for the three months ended December 31, 2023, of $1.0 million compared to net income of $1.7 million reported for the three months ended December 31, 2022. The Company’s basic and diluted earnings per share were $0.33 for the three months ended December 31, 2023, compared to basic and diluted earnings per share of $0.57 and $0.55, respectively, for the three months ended December 31, 2022. The Company reported net income of $2.2 million for the six months ended December 31, 2023, compared to $3.4 million for the six months ended December 31, 2022. The Company’s basic and diluted earnings per share were $0.73 and $0.72, respectively, for the...

NEW YORK , Jan. 25, 2024 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today announced that it will release financial results for the third fiscal quarter ended December 31, 2023, before market open on Wednesday, February 7, 2024. Reservoir will host a conference call to discuss its results at 10 a.m. Eastern Standard Time the same day. A live audio webcast of Reservoir’s third quarter results discussion will be accessible under the Events and Presentations section of the Company’s Investor Relations website at https://investors.reservoir-media.com/news-and-events/events-and-presentations. An archived version of the Company’s webcast will also be available on Reservoir’s website. Interested parties may also participate in the call using the registration...

Pillarstone Breached the Implied Duty of Good Faith and Fair Dealing, Poison Pill Declared Unenforceable HOUSTON, Jan. 25, 2024 (GLOBE NEWSWIRE) — In Whitestone REIT Operating Partnership, L.P. (“Whitestone”) v Pillarstone Capital REIT (“Pillarstone”), the Delaware Court of Chancery issued a ruling today in Whitestone’s favor with the following findings:Whitestone proved that Pillarstone’s adoption of the Rights Agreement (“Poison Pill”) breached the implied covenant of good faith and fair dealing and caused Whitestone harm.That Whitestone may proceed to serve a notice of redemption for some or all of its units without fear of damaging repercussions.That once redemption has occurred and Pillarstone has assigned a current value to the partnership’s assets, the Court of Chancery will enter a monetary judgement against Pillarstone...

The Environment Committee of the European Parliament votes in favour of the European Commission proposal to introduce a new regulation on plants obtained by certain new genomic techniques (NGTs) and their food and feed.The Committee’s report indicates that NGTs have the ability to enhance agriculture by making crops more resilient and sustainable whilst providing unprecedented opportunities for European agriculture and food production. The proposed regulation identifies a ‘Conventional-like’ category of NGT products that would be regulated as conventional varieties, bringing EU policy closer to that of trading partners in UK, North and South America, India, Australia, and Japan Following the positive vote, the legislation will now move to a plenary session of the European Parliament on 5th to 8th of February for a vote on adoption.SAN...

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. As such, the listing matter has been closed.  About Titan Pharmaceuticals Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with utilizing ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions,...